v3.25.4
Investments in and Advances to Joint Ventures - Summary of Financial Statement Impact From Changes In Estimates on an Unconsolidated Joint Ventures (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]      
Operating loss $ 418,074 $ 428,066 $ 288,358
Net Income (Loss) $ 241,139 $ 235,053 $ 161,149
Diluted loss per share $ 2.20 $ 2.12 $ 1.42
Unconsolidated Joint Ventures      
Schedule of Equity Method Investments [Line Items]      
Net Income (Loss) $ 98,700 $ 10,031 $ 3,306
Unconsolidated Joint Ventures | Critical Infrastructure      
Schedule of Equity Method Investments [Line Items]      
Operating loss (29,140) (51,715) (83,398)
Net Income (Loss) $ (21,734) $ (44,682) $ (61,842)
Diluted loss per share $ (0.2) $ (0.4) $ (0.54)